CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TARS

TP-05 (lotilaner) Low Dose

Phase 2
Tarsus Pharmaceuticals, Inc. (TARS)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '27
TARSPhase 2

TP-05 (lotilaner) Low Dose Phase 2 Est. Readout

TP-05 (lotilaner) Low Dose
Oct 2027~
CT.gov
00%
Competitive Landscape

1 competitor in Lyme Disease

View Full Landscape
Drug Information

Target Indication

Lyme Disease

Clinical Trial

NCT07562087

Last updated: 5/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.